Discovery of 3,9-diazabicyclo[4.2.1]nonanes as potent dual orexin receptor antagonists with sleep-promoting activity in the rat
- 1 July 2010
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (14), 4201-4205
- https://doi.org/10.1016/j.bmcl.2010.05.047
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Design and synthesis of conformationally constrained N,N-disubstituted 1,4-diazepanes as potent orexin receptor antagonistsBioorganic & Medicinal Chemistry Letters, 2010
- Discovery of a Potent, CNS‐Penetrant Orexin Receptor Antagonist Based on an N,N‐Disubstituted‐1,4‐diazepane Scaffold that Promotes Sleep in RatsChemMedChem, 2009
- Conformational analysis of N,N-disubstituted-1,4-diazepane orexin receptor antagonists and implications for receptor bindingBioorganic & Medicinal Chemistry Letters, 2009
- Biomedical Application of Orexin/Hypocretin Receptor Ligands in NeuroscienceJournal of Medicinal Chemistry, 2009
- Orexin receptor antagonists: medicinal chemistry and therapeutic potential.Current Topics in Medicinal Chemistry, 2008
- Promotion of sleep by targeting the orexin system in rats, dogs and humansNature Medicine, 2007
- Direct Catalytic Enantioselective Aza‐Diels–Alder ReactionsAngewandte Chemie-International Edition, 2005
- Evaluation of Drug Interactions with P-Glycoprotein in Drug Discovery: In Vitro Assessment of the Potential for Drug-Drug Interactions with P-GlycoproteinCurrent Drug Metabolism, 2002
- Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that Regulate Feeding BehaviorCell, 1998
- The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activityProceedings of the National Academy of Sciences of the United States of America, 1998